Health Canada is recommending against administering the Oxford-AstraZeneca vaccine to people under 55 following new reports of patients developing blood clots in Europe.
CANADA - Health Canada is recommending the provinces and territories suspend use of the Oxford-AstraZeneca COVID-19 vaccine for people under the age of 55.
This is following new reports of patients in Europe developing blood clots. Most of them were women under 55 and the fatality rate is as high as 40 percent.
Health Canada would like the drugmaker to conduct a detailed study on the risks and benefits of the vaccine across multiple age groups.
The National Committee on Immunizations is also recommending against administering the shot to anyone under 55. It has no plans to rescind it's overall approval of the vaccine at this time.

3rd Annual Running with the Bulls Shines
Mischief in Tillsonburg is Under Investigation
Upgrades Completed for Woodstock Disc Golf Course
OPP Enforcement for Civic Holiday Weekend
Woodstock Candidate Profile - Anthony Scalisi
Drug Trafficking Investigation Leads to Charges
EZT Candidate Profile - Don Chowan
Oxford County Requesting Public Input
Norwich Man Charged in Brant County
SPWH Wants You to Know Drinking Risks
Charges Laid after Truck Hits Bridge
Ingersoll Candidate Profile - Mike Tucker
Motorcyclist Killed in Oxford Collision
Tip Tuesday with the Oxford OPP - July 2026
Oxford OPP Briefs - July 28th, 2026
Cat Thrown from Vehicle in Norfolk County
Environment Canada Issues Yellow Watch for Thunderstorms
Oxford Mosquito Traps Tests Positive for West Nile
Woodstock Candidate Profile - Sandeep Sidhu
Comments
Add a comment